$286.12+79.81% · 3M
Moving avg
1W+6.96%
1M+25.37%
3M+89.67%
6M+77.33%
YTD+41.35%
1Y+83.64%
3Y+31.91%
5Y-31.23%
52-week range
$144.26100% of range$238.85
Company health
Value1/6
Growth2/6
Profitability1/6
Health3/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Revenue compounding 11% a year
Risks
- Trades 19% above the average analyst target
- Currently unprofitable
Key statistics
Valuation
Market cap
$13.78B
Enterprise value
$13.91B
P/E ratio (TTM)
-61.14x
P/S ratio (TTM)
2.74x
EV/EBITDA
47.87x
Per share & returns
EPS (TTM)
-$3.77
Dividend yield
0.00%
Beta (1Y)
1.40
30-day change
+25.37%
Trading
Volume (24h)
249.39K
Previous close
$284.37
Shares outstanding
48.17M
About Charles River Laboratories International, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
CRL
Charles River Laboratories International, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker CRL.
Frequently asked questions
What is Charles River Laboratories International, Inc.'s market cap?
Charles River Laboratories International, Inc. (CRL) has a market capitalization of $13.78B.
What sector is Charles River Laboratories International, Inc. in?
Charles River Laboratories International, Inc. operates in the Healthcare sector, Medical - Diagnostics & Research industry.
What exchange does CRL trade on?
CRL trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap